Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dexcom Inc (DXCM)

Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,688,152
  • Shares Outstanding, K 385,873
  • Annual Sales, $ 4,662 M
  • Annual Income, $ 836,300 K
  • EBIT $ 912 M
  • EBITDA $ 1,164 M
  • 60-Month Beta 1.55
  • Price/Sales 5.07
  • Price/Cash Flow 22.11
  • Price/Book 8.70

Options Overview Details

View History
  • Implied Volatility 55.99% (-2.78%)
  • Historical Volatility 33.45%
  • IV Percentile 78%
  • IV Rank 56.67%
  • IV High 77.57% on 10/30/25
  • IV Low 27.78% on 08/05/25
  • Expected Move (DTE 6) 2.28 (3.56%)
  • Put/Call Vol Ratio 1.06
  • Today's Volume 1,418
  • Volume Avg (30-Day) 1,764
  • Put/Call OI Ratio 0.93
  • Today's Open Interest 89,090
  • Open Int (30-Day) 88,017
  • Expected Range 61.70 to 66.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.47
  • Number of Estimates 10
  • High Estimate $0.53
  • Low Estimate $0.42
  • Prior Year $0.32
  • Growth Rate Est. (year over year) +46.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
60.57 +5.63%
on 04/02/26
68.76 -6.95%
on 03/19/26
-3.34 (-4.96%)
since 03/17/26
3-Month
60.57 +5.63%
on 04/02/26
75.97 -15.79%
on 01/22/26
-5.56 (-8.00%)
since 01/16/26
52-Week
54.11 +18.24%
on 11/07/25
89.98 -28.90%
on 07/30/25
-4.59 (-6.69%)
since 04/17/25

Most Recent Stories

More News
3 Reasons Investors Love DexCom (DXCM)

3 Reasons Investors Love DexCom (DXCM)

DXCM : 63.98 (+4.49%)
Q4 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks

Q4 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks

DXCM : 63.98 (+4.49%)
Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...

DXCM : 63.98 (+4.49%)
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2026 financial results after market close on Thursday, April 30, 2026. Management will hold a conference call...

DXCM : 63.98 (+4.49%)
2 Growth Stocks with All-Star Potential and 1 That Underwhelm

2 Growth Stocks with All-Star Potential and 1 That Underwhelm

TASK : 7.42 (+0.95%)
NX : 20.26 (+6.74%)
DXCM : 63.98 (+4.49%)
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

OMCL : 38.28 (+1.81%)
PODD : 203.73 (+1.12%)
ALGN : 190.07 (+2.73%)
DXCM : 63.98 (+4.49%)
QDEL : 12.71 (+0.20%)
2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Headwinds

2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Headwinds

VEEV : 167.95 (+0.16%)
NVR : 7,000.92 (+4.44%)
DXCM : 63.98 (+4.49%)
2 Healthcare Stocks to Target This Week and 1 That Underwhelm

2 Healthcare Stocks to Target This Week and 1 That Underwhelm

HIMS : 28.82 (+6.78%)
NVAX : 8.84 (+2.31%)
DXCM : 63.98 (+4.49%)
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know

Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know

FTRE : 10.38 (+2.87%)
HUM : 205.14 (+2.18%)
PACB : 1.6900 (+3.68%)
ALHC : 21.22 (+1.92%)
DXCM : 63.98 (+4.49%)
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

New registry study data shows that long-term use of Dexcom G7 supports weight management and lowers A1C for people with Type 2 diabetes who aren’t on insulin therapy 1 , ...

DXCM : 63.98 (+4.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of...

See More

Key Turning Points

3rd Resistance Point 66.94
2nd Resistance Point 65.51
1st Resistance Point 64.75
Last Price 63.98
1st Support Level 62.56
2nd Support Level 61.13
3rd Support Level 60.37

See More

52-Week High 89.98
Fibonacci 61.8% 76.28
Fibonacci 50% 72.04
Fibonacci 38.2% 67.81
Last Price 63.98
52-Week Low 54.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.